Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Concerning Cycloserine & Tuberculosis (TB), Cycloserine is an FDA‑approved antibiotic for the treatment of tuberculosis and has longstanding use in MDR‑TB regimens, but it does not have a modern, centrally granted EMA marketing authorisation; in Europe its use is via national‑level approvals and it is considered a WHO group B second‑line drug rather than part of any specific EMA‑approved fixed regimen (1).
The medicine is only on the complementary list. For these items specialized diagnostic or monitoring or specialist training are needed. An item may also be listed as complementary on the basis of higher costs or a less attractive cost-benefit ratio.